As reported by our affiliate in (b)(6), during a mitral valve in valve (viv) procedure, a 29mm sapien 3 valve was implanted in a failing mitral surgical valve by the transfemoral-transseptal approach.After a successful transseptal (ts) puncture, the commander delivery system was advanced via a lunderquist guidewire and positioned for implantation.Due to a sudden pressure drop, a pericardial effusion was suspected and determined to be probably caused by the guidewire manipulation.It was determined that the pericardial effusion was caused by a left ventricular (lv) perforation close to the apex.The patient was resuscitated, and the pericardial effusion puncture site was sutured by the full sternotomy approach.The commander system was successfully recovered and removed from patient.Immediately after the patient was stabilized, a 29mm sapien 3 valve was successfully implanted viv in mitral position by the transapical approach while the chest was still open.At the time of the report, the patient was okay and sent to emergency care.
|
Per the instructions for use (ifu), cardiovascular injuries, including perforation or dissection of vessels, ventricle, myocardium or valvular structures, are potential adverse events associated with standard cardiac catheterization, balloon valvuloplasty and the transcatheter aortic valve replacement (tavr) procedure.There are several potential etiologies for ventricular perforation during a tavr procedure, including perforation by the guidewire, the delivery system, or the transvenous pacer (tvp) lead.Physicians are extensively trained by edwards before they are qualified to use the sapien transcatheter heart valve (thv).Training includes proper guidewire positioning, fixation of the tvp to prevent ventricle perforation, and careful manipulation of devices.Per the procedure didactic, patients with small ventricles are at particularly high risk for ventricular perforation.In this case, there was no allegation or indication a device malfunction contributed to this adverse event.Investigation results suggest in addition to procedural factors (manipulation of the guidewire, devices), patient factors (advanced age - 84 years) may have contributed to the lv perforation during the mitral viv procedure.The ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
|